位置:首页 > 蛋白库 > VDRA_DANRE
VDRA_DANRE
ID   VDRA_DANRE              Reviewed;         453 AA.
AC   Q9PTN2; B3DFZ0;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-MAR-2009, sequence version 2.
DT   03-AUG-2022, entry version 138.
DE   RecName: Full=Vitamin D3 receptor A;
DE            Short=VDR-A;
DE   AltName: Full=1,25-dihydroxyvitamin D3 receptor A;
DE   AltName: Full=Nuclear receptor subfamily 1 group I member 1-A;
GN   Name=vdra; Synonyms=nr1i1a, vdr;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Danionidae; Danioninae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Kouzmenko A.P.;
RT   "Danio rerio vitamin D receptor.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (APR-2008) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=17997606; DOI=10.1371/journal.pgen.0030188;
RA   Bertrand S., Thisse B., Tavares R., Sachs L., Chaumot A., Bardet P.-L.,
RA   Escriva H., Duffraisse M., Marchand O., Safi R., Thisse C., Laudet V.;
RT   "Unexpected novel relational links uncovered by extensive developmental
RT   profiling of nuclear receptor expression.";
RL   PLoS Genet. 3:E188-E188(2007).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 156-453 IN COMPLEX WITH VITAMIN
RP   D3 ANALOG AND NCOA1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17346665; DOI=10.1016/j.abb.2007.01.031;
RA   Rochel N., Hourai S., Perez-Garcia X., Rumbo A., Mourino A., Moras D.;
RT   "Crystal structure of the vitamin D nuclear receptor ligand binding domain
RT   in complex with a locked side chain analog of calcitriol.";
RL   Arch. Biochem. Biophys. 460:172-176(2007).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 156-453 IN COMPLEXES WITH VITAMIN
RP   D3; LIGAND ANALOG AND NCOA1, FUNCTION, INTERACTION WITH NCOA1, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17218092; DOI=10.1016/j.jsbmb.2006.12.003;
RA   Ciesielski F., Rochel N., Moras D.;
RT   "Adaptability of the vitamin D nuclear receptor to the synthetic ligand
RT   Gemini: remodelling the LBP with one side chain rotation.";
RL   J. Steroid Biochem. Mol. Biol. 103:235-242(2007).
CC   -!- FUNCTION: Nuclear receptor for calcitriol, the active form of vitamin
CC       D3 which mediates the action of this vitamin on cells. Enters the
CC       nucleus upon vitamin D3 binding where it forms heterodimers with the
CC       retinoid X receptor/RXR. The VDR-RXR heterodimers bind to specific
CC       response elements on DNA and activate the transcription of vitamin D3-
CC       responsive target genes. Recruited to promoters via its interaction
CC       with BAZ1B/WSTF which mediates the interaction with acetylated
CC       histones, an essential step for VDR-promoter association. Plays a
CC       central role in calcium homeostasis. {ECO:0000250|UniProtKB:P11473}.
CC   -!- SUBUNIT: Homodimer in the absence of bound vitamin D3. Heterodimer with
CC       RXRA after vitamin D3 binding (By similarity). Interacts with ncoa1 and
CC       possibly other coactivators, leading to a strong increase of
CC       transcription of target genes (PubMed:17218092, PubMed:17346665).
CC       {ECO:0000250|UniProtKB:P11473, ECO:0000269|PubMed:17218092,
CC       ECO:0000269|PubMed:17346665}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P11473,
CC       ECO:0000255|PROSITE-ProRule:PRU00407}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P11473}. Note=Localizes mainly to the nucleus.
CC       Translocated into the nucleus via both ligand-dependent and ligand-
CC       independent pathways; ligand-independent nuclear translocation is
CC       mediated by IPO4. {ECO:0000250|UniProtKB:P11473}.
CC   -!- TISSUE SPECIFICITY: Detected in embryo 24 to 48 hours after
CC       fertilization and in gastrula. {ECO:0000269|PubMed:17997606}.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain, a
CC       DNA-binding domain and a C-terminal ligand-binding domain.
CC       {ECO:0000250|UniProtKB:P11473}.
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000250|UniProtKB:P11473}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF164512; AAF21427.1; -; mRNA.
DR   EMBL; BC162213; AAI62213.1; -; mRNA.
DR   EMBL; BC162226; AAI62226.1; -; mRNA.
DR   RefSeq; NP_570994.1; NM_130919.1.
DR   PDB; 2HBH; X-ray; 2.65 A; A=156-453.
DR   PDB; 2HC4; X-ray; 2.20 A; A=156-453.
DR   PDB; 2HCD; X-ray; 2.60 A; A=156-453.
DR   PDB; 3DR1; X-ray; 2.70 A; A=156-453.
DR   PDB; 3O1D; X-ray; 2.40 A; A=156-453.
DR   PDB; 3O1E; X-ray; 2.50 A; A=156-453.
DR   PDB; 4FHH; X-ray; 2.33 A; A=156-453.
DR   PDB; 4FHI; X-ray; 2.40 A; A=156-453.
DR   PDB; 4G1D; X-ray; 2.90 A; A=156-453.
DR   PDB; 4G1Y; X-ray; 2.85 A; A=156-453.
DR   PDB; 4G1Z; X-ray; 2.50 A; A=156-453.
DR   PDB; 4G20; X-ray; 2.90 A; A=156-453.
DR   PDB; 4G21; X-ray; 2.90 A; A=156-453.
DR   PDB; 4G2H; X-ray; 2.50 A; A=156-453.
DR   PDB; 4IA1; X-ray; 2.44 A; A=156-453.
DR   PDB; 4IA2; X-ray; 2.95 A; A=156-453.
DR   PDB; 4IA3; X-ray; 2.70 A; A=156-453.
DR   PDB; 4IA7; X-ray; 2.70 A; A=156-453.
DR   PDB; 4Q0A; X-ray; 1.90 A; C=156-453.
DR   PDB; 4RUJ; X-ray; 2.35 A; A=156-453.
DR   PDB; 4RUO; X-ray; 2.81 A; X=156-453.
DR   PDB; 4RUP; X-ray; 2.75 A; A=156-453.
DR   PDB; 5E7V; X-ray; 2.40 A; A=156-453.
DR   PDB; 5LGA; X-ray; 2.50 A; A=156-453.
DR   PDB; 5MX7; X-ray; 1.98 A; A1=156-453.
DR   PDB; 5NKY; X-ray; 2.10 A; A=156-453.
DR   PDB; 5NMA; X-ray; 2.80 A; A=156-453.
DR   PDB; 5NMB; X-ray; 2.50 A; A2=156-453.
DR   PDB; 5OW7; X-ray; 2.10 A; A=156-453.
DR   PDB; 5OW9; X-ray; 2.40 A; A=156-453.
DR   PDB; 5OWD; X-ray; 2.15 A; A=156-453.
DR   PDB; 6FO7; X-ray; 2.59 A; A=156-453.
DR   PDB; 6FO8; X-ray; 2.30 A; 1=156-453.
DR   PDB; 6FO9; X-ray; 2.70 A; A=156-453.
DR   PDB; 6FOB; X-ray; 2.75 A; A=156-453.
DR   PDB; 6FOD; X-ray; 2.50 A; A=156-453.
DR   PDB; 6T2M; X-ray; 3.00 A; A=156-453.
DR   PDB; 6XZH; X-ray; 2.37 A; A=156-453.
DR   PDB; 6XZI; X-ray; 2.10 A; A=156-453.
DR   PDB; 6XZJ; X-ray; 2.10 A; A=156-453.
DR   PDB; 6XZK; X-ray; 2.00 A; A=156-453.
DR   PDB; 6XZV; X-ray; 2.30 A; A=156-453.
DR   PDB; 7B39; X-ray; 2.13 A; A=156-453.
DR   PDB; 7BNS; X-ray; 2.70 A; A2=156-453.
DR   PDB; 7BNU; X-ray; 2.40 A; A2=156-453.
DR   PDB; 7BO6; X-ray; 2.86 A; A=156-453.
DR   PDB; 7OXZ; X-ray; 2.20 A; A=156-453.
DR   PDB; 7OY4; X-ray; 2.00 A; A=156-453.
DR   PDBsum; 2HBH; -.
DR   PDBsum; 2HC4; -.
DR   PDBsum; 2HCD; -.
DR   PDBsum; 3DR1; -.
DR   PDBsum; 3O1D; -.
DR   PDBsum; 3O1E; -.
DR   PDBsum; 4FHH; -.
DR   PDBsum; 4FHI; -.
DR   PDBsum; 4G1D; -.
DR   PDBsum; 4G1Y; -.
DR   PDBsum; 4G1Z; -.
DR   PDBsum; 4G20; -.
DR   PDBsum; 4G21; -.
DR   PDBsum; 4G2H; -.
DR   PDBsum; 4IA1; -.
DR   PDBsum; 4IA2; -.
DR   PDBsum; 4IA3; -.
DR   PDBsum; 4IA7; -.
DR   PDBsum; 4Q0A; -.
DR   PDBsum; 4RUJ; -.
DR   PDBsum; 4RUO; -.
DR   PDBsum; 4RUP; -.
DR   PDBsum; 5E7V; -.
DR   PDBsum; 5LGA; -.
DR   PDBsum; 5MX7; -.
DR   PDBsum; 5NKY; -.
DR   PDBsum; 5NMA; -.
DR   PDBsum; 5NMB; -.
DR   PDBsum; 5OW7; -.
DR   PDBsum; 5OW9; -.
DR   PDBsum; 5OWD; -.
DR   PDBsum; 6FO7; -.
DR   PDBsum; 6FO8; -.
DR   PDBsum; 6FO9; -.
DR   PDBsum; 6FOB; -.
DR   PDBsum; 6FOD; -.
DR   PDBsum; 6T2M; -.
DR   PDBsum; 6XZH; -.
DR   PDBsum; 6XZI; -.
DR   PDBsum; 6XZJ; -.
DR   PDBsum; 6XZK; -.
DR   PDBsum; 6XZV; -.
DR   PDBsum; 7B39; -.
DR   PDBsum; 7BNS; -.
DR   PDBsum; 7BNU; -.
DR   PDBsum; 7BO6; -.
DR   PDBsum; 7OXZ; -.
DR   PDBsum; 7OY4; -.
DR   AlphaFoldDB; Q9PTN2; -.
DR   SMR; Q9PTN2; -.
DR   BioGRID; 78317; 2.
DR   STRING; 7955.ENSDARP00000063213; -.
DR   BindingDB; Q9PTN2; -.
DR   ChEMBL; CHEMBL3217399; -.
DR   DrugCentral; Q9PTN2; -.
DR   GeneID; 30076; -.
DR   KEGG; dre:30076; -.
DR   CTD; 30076; -.
DR   ZFIN; ZDB-GENE-000210-31; vdra.
DR   eggNOG; KOG3575; Eukaryota.
DR   InParanoid; Q9PTN2; -.
DR   OrthoDB; 297114at2759; -.
DR   PhylomeDB; Q9PTN2; -.
DR   EvolutionaryTrace; Q9PTN2; -.
DR   PRO; PR:Q9PTN2; -.
DR   Proteomes; UP000000437; Genome assembly.
DR   Proteomes; UP000814640; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:1902098; F:calcitriol binding; IDA:ZFIN.
DR   GO; GO:1902121; F:lithocholic acid binding; IDA:ZFIN.
DR   GO; GO:0004879; F:nuclear receptor activity; IDA:ZFIN.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0005499; F:vitamin D binding; IDA:ZFIN.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0055074; P:calcium ion homeostasis; IMP:ZFIN.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0003146; P:heart jogging; IMP:ZFIN.
DR   GO; GO:0001947; P:heart looping; IMP:ZFIN.
DR   GO; GO:0071425; P:hematopoietic stem cell proliferation; IMP:ZFIN.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0001503; P:ossification; IMP:ZFIN.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:ZFIN.
DR   GO; GO:0006351; P:transcription, DNA-templated; IDA:ZFIN.
DR   CDD; cd06955; NR_DBD_VDR; 1.
DR   Gene3D; 1.10.565.10; -; 1.
DR   Gene3D; 3.30.50.10; -; 1.
DR   IDEAL; IID50155; -.
DR   InterPro; IPR042153; DBD_VDR.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR000324; VitD_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   PRINTS; PR00350; VITAMINDR.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; DNA-binding; Metal-binding; Nucleus; Receptor;
KW   Reference proteome; Transcription; Transcription regulation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..453
FT                   /note="Vitamin D3 receptor A"
FT                   /id="PRO_0000337878"
FT   DOMAIN          159..449
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        53..128
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         56..76
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         92..111
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          129..158
FT                   /note="Hinge"
FT                   /evidence="ECO:0000250|UniProtKB:P11473"
FT   REGION          274..292
FT                   /note="Interaction with coactivator LXXLL motif"
FT                   /evidence="ECO:0000250|UniProtKB:P13053"
FT   MOTIF           442..450
FT                   /note="9aaTAD"
FT                   /evidence="ECO:0000250|UniProtKB:P11473"
FT   BINDING         175
FT                   /ligand="calciol"
FT                   /ligand_id="ChEBI:CHEBI:28940"
FT                   /evidence="ECO:0000269|PubMed:17218092,
FT                   ECO:0000269|PubMed:17346665"
FT   BINDING         255..265
FT                   /ligand="calciol"
FT                   /ligand_id="ChEBI:CHEBI:28940"
FT                   /evidence="ECO:0000269|PubMed:17218092,
FT                   ECO:0000269|PubMed:17346665"
FT   BINDING         299..306
FT                   /ligand="calciol"
FT                   /ligand_id="ChEBI:CHEBI:28940"
FT                   /evidence="ECO:0000269|PubMed:17218092,
FT                   ECO:0000269|PubMed:17346665"
FT   BINDING         333
FT                   /ligand="calciol"
FT                   /ligand_id="ChEBI:CHEBI:28940"
FT                   /evidence="ECO:0000269|PubMed:17218092,
FT                   ECO:0000269|PubMed:17346665"
FT   BINDING         423
FT                   /ligand="calciol"
FT                   /ligand_id="ChEBI:CHEBI:28940"
FT                   /evidence="ECO:0000269|PubMed:17218092,
FT                   ECO:0000269|PubMed:17346665"
FT   CONFLICT        24
FT                   /note="R -> T (in Ref. 1; AAF21427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        32
FT                   /note="V -> L (in Ref. 1; AAF21427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        47
FT                   /note="E -> Q (in Ref. 1; AAF21427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        54
FT                   /note="R -> P (in Ref. 1; AAF21427)"
FT                   /evidence="ECO:0000305"
FT   HELIX           158..174
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   HELIX           180..184
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   HELIX           255..274
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   TURN            277..281
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   HELIX           284..302
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   HELIX           303..305
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   TURN            309..312
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   STRAND          313..315
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   HELIX           319..321
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   STRAND          322..324
FT                   /evidence="ECO:0007829|PDB:2HCD"
FT   HELIX           325..328
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   TURN            329..331
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   HELIX           335..349
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   HELIX           355..366
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   STRAND          369..371
FT                   /evidence="ECO:0007829|PDB:7OY4"
FT   HELIX           377..398
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   STRAND          399..401
FT                   /evidence="ECO:0007829|PDB:6XZJ"
FT   HELIX           402..404
FT                   /evidence="ECO:0007829|PDB:2HBH"
FT   HELIX           405..431
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   HELIX           434..437
FT                   /evidence="ECO:0007829|PDB:4Q0A"
FT   HELIX           442..448
FT                   /evidence="ECO:0007829|PDB:4Q0A"
SQ   SEQUENCE   453 AA;  50867 MW;  87DE0415B3FF56CD CRC64;
     MLTENSAVNS GGKSKCEAGA CESRVNGDAT SVMDLMAVST SATGQDEFDR NAPRICGVCG
     DKATGFHFNA MTCEGCKGFF RRSMKRKASF TCPFNGNCTI TKDNRRHCQA CRLKRCIDIG
     MMKEFILTDE EVQRKKDLIM KRKEEEAARE ARKPRLSDEQ MQIINSLVEA HHKTYDDSYS
     DFVRFRPPVR EGPVTRSASR AASLHSLSDA SSDSFNHSPE SVDTKLNFSN LLMMYQDSGS
     PDSSEEDQQS RLSMLPHLAD LVSYSIQKVI GFAKMIPGFR DLTAEDQIAL LKSSAIEIIM
     LRSNQSFSLE DMSWSCGGPD FKYCINDVTK AGHTLELLEP LVKFQVGLKK LKLHEEEHVL
     LMAICLLSPD RPGVQDHVRI EALQDRLCDV LQAYIRIQHP GGRLLYAKMI QKLADLRSLN
     EEHSKQYRSL SFQPEHSMQL TPLVLEVFGS EVS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024